CRO
CDMO
CMO
Testing services
Scientific Customized Peptides
General linear peptide synthesis
Long peptide synthesis
Cyclic peptide synthesis (disulfide ring formation)
Cyclic peptide synthesis (staple peptide)
Stable isotope labeling peptide synthesis
Glycopeptides
Polypeptide modification
Peptide library synthesis
View all
Linker Synthesis Service
ADC Linker Synthesis Service
PDC Drug Synthesis Services
View all
FTE Services
PEPTIDE FTE
View all
Learn more
Popular peptides
Beauty peptides
Drug peptide intermediates and impurities
Cancer antigenic peptide
Catalog peptides
Linker
Synthesis of unnatural amino acids and other blocks
Human body system
HA 12CA5 Epitope
Cys-Angiopep-2
[Ala9]Autocamtide2
(Val²)-Amyloid β-Protein (1-42)
N-Acetyl lysyltyrosylcysteine amide
Acetyl-(D-Arg10,Cys11,D-Phe14,Cys17)-β-MSH (10-17) amide
MPG
Ganirelix
View all
Bioanalytical drug development
Ac-RADARADARADARADAYKKIIKKLRGDSP-NH2
Boc-VLGR-pNA
DADE-S(OGlcNAc)-L
c(His-Phe)
Suc-GP-AMC
Cell Adhesive Peptide [RGDC]
HSV-1-amide UL 26 Open Reading Frame (242-255)
RRAAEELDSRAG-S(OGlcNAc)-PQL
View all
Nano Peptide
DArg9
RADA16
Hel 13-5
LIVAGD
Cadherin Peptide , avian
LF-NH2
FITC-LC-TAT (47-57)
LF
View all
Learn more
Home / Peptide products / ADC Linker / Satralizumab Linker
Filters
Popular peptides
Human body system
Tripeptide Peptide Tag Domain Antagonist peptides Blocker Peptides Antimicrobial peptides Amyloid peptides Inhibitor peptides Targeted Peptide Agonist Peptide
Bioanalytical drug development
RGD Peptides Glycopeptides Dipeptide Cyclodipeptide Substrate Peptide
Nano Peptide
Self-assembling peptides Cell-penetrating Peptides
Beauty peptides
Anti-aging
Anti-inflammatory
Repair
Moisturizing
Whitening
Body care
Drug peptide intermediates and impurities
Neoplasm
Diabetes mellitus
Cardiovascular
Reproductive
Anti-infection
Osteoporosis
Other
Cancer antigenic peptide
Mutation
Differentiation
Overexpressed
Tumor-specific
Catalog peptides
Linker
ADC Linker
Peptide Linker
PDC Linker
RDC linker
PROTAC linker
Reactive Linker
Alkyne Reactive Linker Amine Reactive Linker Azide Reactive Linker Click Reactive Linker Thiol Reactive Linker
Linker Intermediate
Advanced Linker Intermediate
Synthesis of unnatural amino acids and other blocks
Fmoc protects unnatural amino acids
Satralizumab Linker
Name
Satralizumab Linker
Molecular structural formula
Purity
≥95%
CAS Number
1491917-83-9
Formula
C76H104N12O24S
MW
1601.8
Target
Antibody-Drug Conjugates (ADCs) TROP2
InChIKey
ULRUOUDIQPERIJ-PQURJYPBSA-N
Solubility in water
25 mg/mL
References
[1]. Cardillo TM, et al. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31. [2]. Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) [published correction appears in Oncotarget. 2020 Mar 10;11(10):942]. Oncotarget. 2015;6(26):22496-22512.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Sacituzumab govitecan  is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.